FIELD: medicine.
SUBSTANCE: what is described is a gel containing structured nanovesicles - niosomes prepared from silicone compounds with enclosed albendazole, anthelmintic preparation.
EFFECT: invention enables extending the range of application of the anthelmintic preparations by reducing dyspeptic reactions that makes them applicable in both adults, and children suffering gastrointestinal diseases.
| Title | Year | Author | Number |
|---|---|---|---|
| DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
| PHARMACEUTICAL NIOSOMAL GEL BASED ON N-HYDROXY-2-(2-(NAPHTALENE-2-YL)-1H-INDOLE-3-YL)-2-PHENYLACETAMIDE WITH ANTI-TUMOUR ACTIVITY TO GLIOBLASTOMA | 2015 |
|
RU2627449C2 |
| METHOD FOR TRANSDERMAL TRANSFER OF ACTIVE SUBSTANCES WITH USE OF PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539396C2 |
| METHOD FOR MAKING TRANSDERMAL PATCH CONTAINING PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539397C2 |
| ANTHELMINTHIC AGENT | 1998 |
|
RU2153329C2 |
| NIOSOMAL ANTIMICROBIAL GEL FOR TREATING DIABETIC ULCERS, WOUNDS, BURNS, INCLUDING THOSE INFECTED WITH ANTIBIOTIC-RESISTANT MICROORGANISMS | 2021 |
|
RU2781402C2 |
| DENTAL GEL HAVING NIOSOMES FOR TREATMENT OF INFLAMMATORY AND DYSTROPHIC PERIODONTAL DISEASES | 2013 |
|
RU2582290C2 |
| ANTHELMINTIC AGENT | 2001 |
|
RU2195280C1 |
| METHOD OF PRODUCING NIOSOMAL FORM OF OFLOXACIN | 2014 |
|
RU2583135C1 |
| ANTIPARASITIC AGENT BASED ON ALBENDAZOLE AND METHOD OF ITS USE FOR TREATMENT OF HELMINTHOSES OF MAMMALS | 2014 |
|
RU2546535C1 |
